A
$ Value
$0
Shares
51,714
Price
$0
Filed
Feb 13
Insider
Name
Teehan Brendan
Title
Chief Commercial Officer
CIK
0001891900
Roles
Officer
Transaction Details
Transaction Date
2026-02-11
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
100,934
Footnotes
Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Filing Info
Teehan Brendan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | PCRX | A | $0 |
| 2026-01-30 | PCRX | F | $106K |
| 2025-12-31 | PCRX | A | $4K |
Other Insiders at PCRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILLIAMS KRISTEN
Chief Administrative Officer
|
— | $270K | 2026-02-11 |
|
RIKER LAUREN
Senior Vice President, Finance
|
— | $83K | 2026-02-11 |
|
Cross Shawn
Chief Financial Officer
|
— | $303K | 2026-04-22 |
| Hirawat Samit | — | — | 2026-01-27 |
|
Lee Frank D.
Chief Executive Officer
|
— | — | 2026-02-11 |
|
SLONIN JONATHAN
Chief Medical Officer
|
— | — | 2026-02-11 |
|
Teehan Brendan
Chief Commercial Officer
|
— | — | 2026-01-30 |